SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
17342<i>What's Gary Wilcox up to these days??</i> New Company Formedscaram(o)uche-9/19/2008
17341Hot Stocks story about XOMA XOMA announced the initiation of new therapeutic antbob zagorin-9/15/2008
17340thestreet.com / feuerstein.. "...John R. took a look at the new diabetes dbob zagorin-9/13/2008
17339Anybody else think this is interesting?keokalani'nui-9/8/2008
17338XOMA 052 Clinical Results Support New Type 2 Diabetes Therapeutic Approach of Tabob zagorin-9/8/2008
17337don't know. i will probably sell if it gets above 3.5 or so because i have abob zagorin-7/21/2008
17336XOMA went under $2.00 now seems to be coming back--------is the RBC evaluation sMJ-7/21/2008
17335XOMA Making the Right Moves Advancement of XOMA-052 in the current phase I trialbob zagorin-5/14/2008
17334XOMA PLATFORM FAR UNDERVALUED Mar 13, 2008 (Zacks Investment Research via bob zagorin-3/13/2008
17333XOMA Rated New `Outperform' at RBC Capital :XOMA US 2008-03-04 16:49 (New Yobob zagorin-3/5/2008
17332new from zacks... UPDATE Sales of all products that Xoma recieves a royalty onbob zagorin-2/20/2008
17331WASHINGTON, Dec 26 (Reuters) - U.S. biotechnology firm XOMA Ltd (XOMA.O: Quote, bob zagorin-12/26/2007
17330Biotech Notebook: Xoma, Medivation, Delcath By Adam Feuerstein Senior Writer 11/bob zagorin-11/28/2007
17329Rating reiterations for Nov. 27 from Briefing.com: Company Symbol Brokerage Firmbob zagorin-11/27/2007
17328XOMA Announces Conference Call to Provide Overview of Business Strategy Monday Nbob zagorin-11/27/2007
17327Coverage Reit/Price Tgt Changed* Sort alphabetically | Sort by brokers Company bob zagorin-11/27/2007
17326full transcript with Q/A seekingalpha.combob zagorin-11/9/2007
17325Briefing.com (XOMA) Ticker Alert for Upgrades/Downgrades Company Ticker Bfmikehugo-10/12/2007
17324xml.10kwizard.comnowandthen-10/10/2007
17323No news,but lots of action.nowandthen-10/2/2007
17322XOMA Initiates Phase 1 European Trial in Diabetes for XOMA 052, a Novel Anti-IL-bob zagorin-9/12/2007
17321Xoma Buddies Up To Pfizer (Forbes) Steve Schaefer, 08.28.07, 4:21 PM ET Xoma Libob zagorin-8/29/2007
17320Alliance with Pfizer 10:55 XOMA XOMA Limited: Alliance with Pfizer provides clbob zagorin-8/28/2007
17319xoma has 12.5 shares short as of august data. should be a nice little squeeze.. bob zagorin-8/28/2007
17318very nice...bob zagorin-8/28/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News